BPBenedetta Pettorini

Benedetta Pettorini

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Benedetta Pettorini has a total of 70 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Craniopharyngiomas

    by B. J. Hall, M. A. Cinalli, C. Mallucci, B. L. Pettorini

  • Creating a Selective Dorsal Rhizotomy Team

    by Benjamin J. Hall, Conor S. Gillespie, Christine Sneade, Alder Hey Children’s Hospital Physiotherapy Group, Deborah Quirk, Dawn Hennigan, Benedetta Pettorini

    Selective dorsal rhizotomy (SDR) is becoming increasingly popular in the management of spasticity in children. Spasticity itself is a multifaceted clinical entity that requires a holistic approach in order to effectively care for and improve the quality of life of those affected. To deliver these goals, a broad multidisciplinary team is required. From the role of neurosurgery in undertaking the procedure, through to the comprehensive rehabilitation process supported by physiotherapy, this chapter aims to summarise the key features necessary for an SDR unit to succeed as a team when providing care to their patients.


  • Patient Selection in Selective Dorsal Rhizotomy (SDR)

    by Benjamin J. Hall, Conor S. Gillespie, Christine Sneade, Alder Hey Children’s Hospital Physiotherapy Group, Deborah Quirk, Dawn Hennigan, Benedetta Pettorini

    For almost as long as selective dorsal rhizotomy (SDR) has existed, there has been debate surrounding which patients should be eligible to undergo the procedure. The selection criteria used to identify suitable surgical candidates have remained largely unchanged for the last three decades, despite the popularity and use of the procedure increasing. Historically, those aged between 3 and 9 years, those of GMFCS level 2 or 3, and those without evidence of dystonia were considered for SDR. In recent years, as the procedure has continued to develop, however, these parameters are expanding, with evidence to suggest a much broader cohort of patients may benefit from SDR than once thought. This chapter seeks to review current practice in patient selection for SDR, as well as the potential directions that this controversial discussion may move towards in the future.


  • Open Access

    Correction to: Safety and effectiveness of Evicel® fibrin sealant as an adjunct to sutured dural repair in children undergoing cranial neurosurgery

    by Gnanamurthy Sivakumar, Shailendra Magdum, Kristian Aquilina, Jothy Kandasamy, Vivek Josan, Bogdan Ilie, Ellie Barnett, Richard Kocharian, Benedetta Pettorini


  • Open Access

    Safety and effectiveness of Evicel® fibrin sealant as an adjunct to sutured dural repair in children undergoing cranial neurosurgery

    by Gnanamurthy Sivakumar, Shailendra Magdum, Kristian Aquilina, Jothy Kandasamy, Vivek Josan, Bogdan Ilie, Ellie Barnett, Richard Kocharian, Benedetta Pettorini

    Purpose: Cerebrospinal fluid (CSF) leakage is a challenging complication of intradural cranial surgery, and children are particularly at risk. The use of dural sealants confers protection in adults, but pediatric studies are scarce. We evaluated the safety and efficacy of Evicel® fibrin sealant as an adjunct to primary dural suturing in children undergoing cranial surgery. Methods: A multicenter trial prospectively enrolled pediatric subjects (< 18 years) undergoing cranial neurosurgery who, upon completion of primary sutured dural repair, experienced CSF leakage. As agreed by the EMA Evicel® Pediatric Investigation Plan, 40 subjects were intra-operatively randomized 2:1 to Evicel® or additional sutures (‘Sutures’). Data analysis was descriptive. The efficacy endpoint was treatment success rate, with success defined as intra-operative watertight closure after provocative Valsalva maneuver (primary endpoint). Safety endpoints were postoperative CSF leakage (incisional CSF leakage, pseudomeningocele or both) and surgical site complications (secondary endpoints). Results: Forty subjects (0.6–17 years) were randomized to Evicel® (N = 25) or Sutures (N = 15) (intention-to-treat). Intracranial tumor was the most common indication and procedures were mostly supratentorial craniotomies. Success rates were 92.0% for Evicel® and 33.3% for Sutures, with a 2.76 estimated ratio of success rates (Farrington-Manning 95% CI [1.53, 6.16]). Sensitivity analyses in per-protocol and safety sets showed similar results. Despite a higher rescue treatment rate, the frequencies of postoperative CSF leakage and wound complications were higher for Sutures than for Evicel®. Conclusion: This small-scale prospective study shows Evicel® treatment to be safe and effective as an adjunct to primary sutured dura mater closure in a pediatric population. Compared to additional sutures, Evicel® was associated with reduced postoperative CSF leakage and surgical site complications. (Trial registration: The trial was registered as NCT02309645 and EudraCT 2013-003558-26).


  • Open Access

    Magnetic Resonance Imaging during Proton Therapy Irradiation Allows for the Early Response Assessment of Pediatric Chordoma

    by Sabina Vennarini, Dante Amelio, Stefano Lorentini, Giovanna Stefania Colafati, Antonella Cacchione, Rita De Vito, Andrea Carai, Benedetta Pettorini, Maurizio Amichetti, Angela Mastronuzzi

    Chordoma in pediatric patients is very rare. Proton therapy has become a gold standard in the treatment of these neoplasms, as high dose escalation can be achieved regarding the target while maximizing the sparing of the healthy tissues near the tumor. The aim of the work was to assess the evolution of morphological sequences during treatment using T1/T2-weighted magnetic resonance imaging (MRI) for the early response assessment of a classic chordoma of the skull base in a pediatric patient who had undergone surgical excision. Our results demonstrated a significant quantitative reduction in the residual nodule component adhered to the medullary bulb junction, with an almost complete recovery of normal anatomy at the end of the irradiation treatment. This was mainly shown in the T2-weighted MRI. On the other hand, the classic component of the lesion was predominantly present and located around the tooth of the axis. The occipital condyles were morphologically and dimensionally stable for the entire irradiation period. In conclusion, the application of this type of monitoring methodology, which is unusual during the administration of a proton treatment for chordoma, highlighted the unexpected early response of the disease. At the same time, it allowed the continuous assessment of the reliability of the treatment plan.

  • NSRG-12. EXPERIENCE WITH THE INTRAOPERATIVE MAGNETIC RESONANCE IN PEDIATRIC BRAIN TUMOR SURGERY

    by Sonia Tejada, Shivaram Avula, Benedetta Pettorini, Conor Mallucci

    The intraoperative magnetic resonance scanner (ioMR) is a diagnostic tool that can be used to improve brain tumor resection in pediatric patients. was introduced in our unit in 2009, and has been used routinely since then. To describe indications, radiological features and clinical outcomes of the patients operated on with ioMRI and analyze our experience. A retrospective analysis of a prospective surgical database has been performed, including surgical procedure, intent, radiological reports, need for second look surgery and complications, supplemented by further review of the clinical notes and the scans. From 2009 to 2015, 216 surgical procedures with ioMR for patients with brain tumors were performed: 204 were craniotomies and 12 were biopsies or cyst drainages. The mean age was 9.3y. One ioMR was performed in 56% patients; the mean duration of the MR was 32 min. In 129 cases (60%) no actions followed the ioMR. When the aim of the surgery was debulking of the tumor, the percentage of patients in which the ioMR was followed by resection was higher than when complete resection was the aim (55 vs 29%). The complication rate was not increased when compared with our previous results (infection 1%, neurological deficits 12%). We have demonstrated that the ioMR can be used safely and routinely in pediatric neurosurgical procedures for brain tumors at any age, assisting the surgeon in achieving the best extent of resection and aiding in intra-operative decision-making for tumor related intracranial pathology.

  • Neurofibroma of the cervical spine in infants

    by Emmanuel Isaac, Jozsef Lang, Ajay Sinha, Benedetta Pettorini


  • Achieving a consensus on managing idiopathic thickening of the pituitary stalk through a national multidisciplinary forum, meeting virtually

    by Nambisan Aparna Kesavath Raman, Maria Michaelidou, Eftychia Dimitrakopoulou, Ash Ederies, Helen Spoudeas, Peter Clayton, Indi Banerjee, Johannes Visser, Jo Blair, Evelien Gevers, et al.

    Objectives: In 2010 we piloted a national multidisciplinary (MDT), meeting virtually to improve management of rare suprasellar (HPAT) tumours. In 2014 we reported centralised treatment decision-making in craniopharyngioma and now wished to examine whether centre based management of idiopathic thickening of the pituitary stalk (iTPS) differs and can be streamlined by wider debate. This might also inform current commissioned BSPED and CCLG guidance. Methods: We assessed centre uptake of HPAT MDT recommendations of 20 iTPS cases from five centres between 1.1.12 and 1.6.15 and their endocrine outcomes by case note review. MRI 3D volume was analysed with ITK-SNAP v 3.2.0 (www.itksnap.org) Software and with centralised radiology review. Results: Patients presented at mean age 8.9 (range 3–16) years with low height −0.8 (−4.5 to 1.1) and weight −0.2 (−3.63 to 2.26) SDS but higher BMI +0.44 (−1.59 to 2.43) SDS. 75% (15) had polydipsia but 80% (16) confirmed DI, 55%(11) were GHd with ACTHd (4), TSHd (2), or Gnd(1) and two had visual dysfunction. One centre presented two biopsied histiocytosis cases. In 60% (12) a watch and wait strategy was recommended, and centres deferred GH replacement in 50%. All underwent PST, serum HCG and AFP, but only 55% had CSF markers, 66% plasma ACE, and 77% skeletal surveys and ophthalmic review. MDT discussion influenced management in 40% and debate in 60%. At an average 2 (0.26–4.5) years follow up, three more (15%) developed TSHd and ACTHd but not DI or GHd. Height 0.2 (−3.4 to 2.3) SDS improved and BMI +0.46 (−3.1 to 3.7) were unchanged. 8 (40%) cases remained idiopathic with stable scans, TPS disappeared in 2 (10%) within 2 years, decreased in 3 (15%), worsened in 1 (5%) and 20% awaited scans. MRI 3Dvolume did not correlate with initial endocrinopathy. Conclusion: Centres have valued the opportunity to discuss this rare and complex condition where management is controversial and differs. This forum has enabled wider discussion, consensus and audit of practice and outcomes which can inform national guidance.